Evidence map›Paper›PMID 42452341›Full record

ArticleJournal of clinical medicine2026

Sex Differences in Heart Failure Epidemiology and Clinical Characteristics in Spain: A Nationwide Population-Based Study.

Andrea Severo, Diego Alvaredo Rodrigo, Javier González Martín, Sonia Rivas García, Irene Marco, Beatriz Palacios, Victoria González, Margarita Capel, Javier de Juan Bagudá, Fernando Arribas Ynsaurriaga and 2 more

Abstract read
In one paragraph

Article in Journal of clinical medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Andrea SeveroCardiology, Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), 28041 Madrid, Spain.ORCID 0000-0003-1773-9656
Diego Alvaredo RodrigoInstituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), 28041 Madrid, Spain.
Javier González MartínCardiology, Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), 28041 Madrid, Spain.
Sonia Rivas GarcíaCardiology, Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), 28041 Madrid, Spain.
Irene MarcoCardiology, Hospital Clínico San Carlos, 28040 Madrid, Spain.
Beatriz PalaciosBioPharmaceuticals Medical, AstraZeneca, 28050 Madrid, Spain.ORCID 0009-0002-0089-2291
Victoria GonzálezBioPharmaceuticals Medical, AstraZeneca, 28050 Madrid, Spain.
Margarita CapelBioPharmaceuticals Corporate Affairs & Market Access, AstraZeneca, 28050 Madrid, Spain.
Javier de Juan BagudáCardiology, Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), 28041 Madrid, Spain.
Fernando Arribas YnsaurriagaCardiology, Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), 28041 Madrid, Spain.
María Dolores García-Cosío CarmenaCardiology, Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), 28041 Madrid, Spain.
Juan Francisco Delgado JiménezCardiology, Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), 28041 Madrid, Spain.ORCID 0000-0002-5401-8324

Funding

AstraZeneca (Spain) 0
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

epidemiologyheart failureleftsex factorsventricular function

Identifiers

PMID42452341
PMCPMC13360783

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.